Home Biosimilar Antibodies Others Others antibody Vilobelimab (Anti-Complement C5) For research use only.
Not for use in humans.

Vilobelimab (Anti-Complement C5)

Synonyms: CaCP-29, IFX-1

Vilobelimab (Anti-Complement C5) is a monoclonal antibody targeting C5a, a pro-inflammatory complement division product that plays a central role in mediating organ dysfunction. It may be used in studies related to sepsis, COVID-19, etc. MW :145.9 KD.

Vilobelimab (Anti-Complement C5)

Purity & Quality Control

Batch: A310101 Purity: 99% Protein concentration: 5.5mg/ml Endotoxin Level: ＜1EU/mg
99

Biological Activity

Description Vilobelimab (Anti-Complement C5) is a monoclonal antibody targeting C5a, a pro-inflammatory complement division product that plays a central role in mediating organ dysfunction. It may be used in studies related to sepsis, COVID-19, etc. MW :145.9 KD.

Product Details

CAS No. 2250440-41-4
Isotype Human IgG4SP
Source CHO
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Comparison of Clones for

*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Vilobelimab (Anti-Complement C5) | Vilobelimab (Anti-Complement C5) supplier | purchase Vilobelimab (Anti-Complement C5) | Vilobelimab (Anti-Complement C5) cost | Vilobelimab (Anti-Complement C5) manufacturer | order Vilobelimab (Anti-Complement C5) | Vilobelimab (Anti-Complement C5) distributor